Hippocampal hyperactivity in a rat model of Alzheimer’s disease DOI Creative Commons

Liudmila Sosulina,

Manuel Mittag,

Hans‐Rüdiger Geis

et al.

Journal of Neurochemistry, Journal Year: 2021, Volume and Issue: 157(6), P. 2128 - 2144

Published: Feb. 14, 2021

Neuronal network dysfunction is a hallmark of Alzheimer's disease (AD). However, the underlying pathomechanisms remain unknown. We analyzed hippocampal micronetwork in transgenic McGill-R-Thy1-APP rats (APPtg) at beginning extracellular amyloid beta (Aβ) deposition. established two-photon Ca2+ -imaging vivo hippocampus and found hyperactivity CA1 neurons. Patch-clamp recordings brain slices vitro revealed increased neuronal input resistance prolonged action potential width pyramidal did neither observe changes synaptic inhibition, nor excitation. Our data support view that intrinsic excitability neurons may precede inhibitory an early stage Aβ-deposition progression.

Language: Английский

GSK3: A potential target and pending issues for treatment of Alzheimer's disease DOI Creative Commons
Jiahui Zhao, Mengying Wei,

Min‐Song Guo

et al.

CNS Neuroscience & Therapeutics, Journal Year: 2024, Volume and Issue: 30(7)

Published: July 1, 2024

Abstract Glycogen synthase kinase‐3 (GSK3), consisting of GSK3α and GSK3β subtypes, is a complex protein kinase that regulates numerous substrates. Research has observed increased GSK3 expression in the brains Alzheimer's disease (AD) patients models. AD neurodegenerative disorder with diverse pathogenesis notable cognitive impairments, characterized by Aβ aggregation excessive tau phosphorylation. This article provides an overview GSK3's structure regulation, extensively analyzing its relationship factors. overactivation disrupts neural growth, development, function. It directly promotes phosphorylation, amyloid precursor (APP) cleavage, leading to formation, or indirectly triggers neuroinflammation oxidative damage. We also summarize preclinical research highlighting inhibition activity as primary therapeutic approach for AD. Finally, pending issues like lack highly specific affinity‐driven inhibitors, are raised expected be addressed future research. In conclusion, represents target treatment, filled hope, challenges, opportunities, obstacles.

Language: Английский

Citations

13

Neuronally differentiated macula densa cells regulate tissue remodeling and regeneration in the kidney DOI Creative Commons
Georgina Gyarmati, Urvi Nikhil Shroff, Anne Riquier‐Brison

et al.

Journal of Clinical Investigation, Journal Year: 2024, Volume and Issue: 134(11)

Published: April 10, 2024

Tissue regeneration is limited in several organs including the kidney, contributing to high prevalence of kidney disease globally. However, evolutionary and physiological adaptive responses presence renal progenitor cells suggest existing remodeling capacity. This study uncovered endogenous tissue mechanisms that were activated by loss body fluid salt regulated a unique niche minority cell type called macula densa (MD). Here we identified neuronal differentiation features MD sense local systemic environment, secrete angiogenic, growth extracellular matrix factors, cytokines chemokines, control resident cells. Serial intravital imaging, nerve factor receptor Wnt mouse models transcriptome analysis revealed cellular molecular these functions. Human therapeutic translation studies illustrated clinical potential factors CCN1 as urinary biomarker target chronic disease. The concept neuronally differentiated key sensory regulatory responding organ-specific inputs controls progenitors remodel or repair tissues may be applicable other diverse regenerative strategies.

Language: Английский

Citations

9

CRISPR-based epigenetic editing of Gad1 improves synaptic inhibition and cognitive behavior in a Tauopathy mouse model DOI Creative Commons
Lei Wan, Ping Zhong, Pei Li

et al.

Neurobiology of Disease, Journal Year: 2025, Volume and Issue: 206, P. 106826 - 106826

Published: Feb. 1, 2025

Language: Английский

Citations

1

An Unbalanced Synaptic Transmission: Cause or Consequence of the Amyloid Oligomers Neurotoxicity? DOI Open Access
Miriam Sciaccaluga, Alfredo Megaro, G. Bellomo

et al.

International Journal of Molecular Sciences, Journal Year: 2021, Volume and Issue: 22(11), P. 5991 - 5991

Published: June 1, 2021

Amyloid-β (Aβ) 1-40 and 1-42 peptides are key mediators of synaptic cognitive dysfunction in Alzheimer's disease (AD). Whereas AD, Aβ is found to act as a pro-epileptogenic factor even before plaque formation, amyloid pathology has been detected among patients with epilepsy increased risk developing AD. Among aggregated species, soluble oligomers suggested be responsible for most Aβ's toxic effects. exert extracellular intracellular toxicity through different mechanisms, including interaction membrane receptors the formation ion-permeable channels cellular membranes. These damages, linked an unbalance between excitatory inhibitory neurotransmission, often result neuronal hyperexcitability neural circuit dysfunction, which turn increase deposition facilitate neurodegeneration, resulting Aβ-driven vicious loop. In this review, we summarize representative literature on effects that oligomeric induces network disorganization.

Language: Английский

Citations

46

Hippocampal hyperactivity in a rat model of Alzheimer’s disease DOI Creative Commons

Liudmila Sosulina,

Manuel Mittag,

Hans‐Rüdiger Geis

et al.

Journal of Neurochemistry, Journal Year: 2021, Volume and Issue: 157(6), P. 2128 - 2144

Published: Feb. 14, 2021

Neuronal network dysfunction is a hallmark of Alzheimer's disease (AD). However, the underlying pathomechanisms remain unknown. We analyzed hippocampal micronetwork in transgenic McGill-R-Thy1-APP rats (APPtg) at beginning extracellular amyloid beta (Aβ) deposition. established two-photon Ca2+ -imaging vivo hippocampus and found hyperactivity CA1 neurons. Patch-clamp recordings brain slices vitro revealed increased neuronal input resistance prolonged action potential width pyramidal did neither observe changes synaptic inhibition, nor excitation. Our data support view that intrinsic excitability neurons may precede inhibitory an early stage Aβ-deposition progression.

Language: Английский

Citations

45